January 09, 2023
A newly created Pre-plated Deubiquitinase Screening Set has been added to our rapidly expanding family of Pre-plated Fragment Screening Sets!
It comprises 3,200 drug-like screening compounds of potential deubiquitinase modifiers, selected with ligand-based and receptor-based drug design methods against ubiquitin-specific proteases USP1 and USP2.
- Novel screening compounds synthesized in-house
- Chemoinformatics assistance
- Only drug-like molecules: Lipinski's Rule of Five and Veber criteria compliant
- No PAINS (A, B, C families), toxic, reactive, and unstable compounds
- Over 90 % purity confirmed by LCMS and/or NMR data
- Hit re-supply, product scale-up
- Compound library design, combinatorial synthesis based on hits found
- Competitive pricing and convenient terms
Please, contact us at email@example.com for any additional information and price quotations.
For a detailed description and other formatting options, please, refer to the full Deubiquitinase Screening Libraries
Related products not to be missed: